Author:
Kwon Yumi,Park Seong-Jun,Nguyen Binh Thanh,Kim Mi Jeong,Oh Sejin,Lee Hwanho,Park Narae,Kim Hyun Seok,Kang Min-Jung,Min Byung Soh,Lee Jin-Won,Yang Eun Gyeong,Lee Cheolju
Abstract
AbstractThe role of matrix metalloproteinase-2 (MMP-2) in tumor cell migration has been widely studied, however, the characteristics and effects of MMP-2 in clinical sample of metastatic colorectal cancer (CRC) remain poorly understood. Here, in order to unveil the perturbed proteomic signal during MMP-2 induced cancer progression, we analyzed plasma proteome of CRC patients according to disease progression, HCT116 cancer secretome upon MMP-2 knockdown, and publicly available CRC tissue proteome data. Collectively, the integrative analysis of multi-layered proteomes revealed that a protein cluster containing EMT (Epithelial-to-Mesenchymal Transition)-associated proteins such as CD9-integrin as well as MMP-2. The proteins of the cluster were regulated by MMP-2 perturbation and exhibited significantly increased expressions in tissue and plasma as disease progressed from TNM (Tumor, Node, and Metastasis) stage I to II. Furthermore, we also identified a plausible association between MMP-2 up-regulation and activation of focal adhesion kinase signaling in the proteogenomic analysis of CRC patient tissues. Based on these comparative and integrative analyses, we suggest that the high invasiveness in the metastatic CRC resulted from increased secretion of MMP-2 and CD9-integrin complex mediated by FAK signaling activation.
Funder
National Research Foundation of Korea
Korea Health Industry Development Institute
Korea Institute of Science and Technology
Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. Noone, A. H., N., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, DR., Chen, HS., Feuer, EJ. Cronin, KA. SEER Cancer Statistics Review (CSR) 1975–2015, < https://seer.cancer.gov/csr/1975_2015/> (2018).
2. Law, W. L., Chan, W. F., Lee, Y. M. & Chu, K. W. Non-curative surgery for colorectal cancer: Critical appraisal of outcomes. Int. J. Colorectal Dis. 19, 197–202. https://doi.org/10.1007/s00384-003-0551-7 (2004).
3. Guan, X. Cancer metastases: Challenges and opportunities. Acta Pharmac. Sin. B 5, 402–418. https://doi.org/10.1016/j.apsb.2015.07.005 (2015).
4. Valastyan, S. & Weinberg, R. A. Tumor metastasis: Molecular insights and evolving paradigms. Cell 147, 275–292. https://doi.org/10.1016/j.cell.2011.09.024 (2011).
5. Vanharanta, S. & Massague, J. Origins of metastatic traits. Cancer Cell 24, 410–421. https://doi.org/10.1016/j.ccr.2013.09.007 (2013).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献